WaveBreak is taking a transformative approach to drug discovery, targeting the fleeting intermediates that are central to many disease pathways but have been beyond the reach of conventional drug discovery approaches.

Our focus is on several of the most prominent unmet medical needs of our time: Neurodegeneration in Parkinson’s disease, Lewy body dementia, Alzheimer’s disease, and ALS.